 |
|
Elevated Monoamine Oxidase A Levels in the Brain
An Explanation for the Monoamine Imbalance of Major Depression
Jeffrey H. Meyer, MD, PhD;
Nathalie Ginovart, PhD;
Anahita Boovariwala, BSc;
Sandra Sagrati, BSc;
Doug Hussey, BSc;
Armando Garcia, BSc;
Trevor Young, MD, PhD;
Nicole Praschak-Rieder, MD;
Alan A. Wilson, PhD;
Sylvain Houle, MD, PhD
Arch Gen Psychiatry. 2006;63:1209-1216.
Context The monoamine theory of depression proposes that monoamine levels are lowered, but there is no explanation for how monoamine loss occurs. Monoamine oxidase A (MAO-A) is an enzyme that metabolizes monoamines, such as serotonin, norepinephrine, and dopamine.
Objective To determine whether MAO-A levels in the brain are elevated during untreated depression.
Setting Tertiary care psychiatric hospital.
Patients Seventeen healthy and 17 depressed individuals with major depressive disorder that met entry criteria were recruited from the care of general practitioners and psychiatrists. All study participants were otherwise healthy and nonsmoking. Depressed individuals had been medication free for at least 5 months.
Main Outcome Measure Harmine labeled with carbon 11, a radioligand selective for MAO-A and positron emission tomography, was used to measure MAO-A DVS(specific distribution volume), an index of MAO-A density, in different brain regions (prefrontal cortex, anterior cingulate cortex, posterior cingulate cortex, caudate, putamen, thalamus, anterior temporal cortex, midbrain, hippocampus, and parahippocampus).
Results The MAO-A DVS was highly significantly elevated in every brain region assessed (t test; P = .001 to 3x10–7). The MAO-A DVS was elevated on average by 34% (2 SDs) throughout the brain during major depression.
Conclusions The sizable magnitude of this finding and the absence of other compelling explanations for monoamine loss during major depressive episodes led to the conclusion that elevated MAO-A density is the primary monoamine-lowering process during major depression.
Author Affiliations: Vivian M. Rakoff PET Imaging Centre (Drs Meyer, Ginovart, Praschak-Rieder, Wilson, and Houle, Mss Boovariwala and Sagrati, and Messrs Hussey and Garcia) and Mood and Anxiety Disorders Division (Drs Meyer and Young), Clarke Division, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, Ontario; and Department of General Psychiatry, Medical University of Vienna, Vienna, Austria (Dr Praschak-Rieder).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Brain Monoamine Oxidase A Binding in Major Depressive Disorder: Relationship to Selective Serotonin Reuptake Inhibitor Treatment, Recovery, and Recurrence
Meyer et al.
Arch Gen Psychiatry 2009;66:1304-1312.
ABSTRACT
| FULL TEXT
Ethical and Cultural Considerations in Delivering Psychiatric Diagnosis: Reconciling the Gap Using MDD Diagnosis Delivery in Less-Acculturated Chinese Patients
Yeung and Kam
Transcultural Psychiatry 2008;45:531-552.
ABSTRACT
Assessing the Assessment of Brain Serotonin Turnover--Reply
Barton et al.
Arch Gen Psychiatry 2008;65:1223-1224.
FULL TEXT
Seasonal Variation in Human Brain Serotonin Transporter Binding
Praschak-Rieder et al.
Arch Gen Psychiatry 2008;65:1072-1078.
ABSTRACT
| FULL TEXT
Brain Monoamine Oxidase A Activity Predicts Trait Aggression
Alia-Klein et al.
J. Neurosci. 2008;28:5099-5104.
ABSTRACT
| FULL TEXT
Major Depressive Disorder
Belmaker and Agam
NEJM 2008;358:55-68.
FULL TEXT
Elevated Brain Serotonin Turnover in Patients With Depression: Effect of Genotype and Therapy
Barton et al.
Arch Gen Psychiatry 2008;65:38-46.
ABSTRACT
| FULL TEXT
5-HTT Binding in Recovered Depressed Patients and Healthy Volunteers: A Positron Emission Tomography Study With [11C]DASB
Bhagwagar et al.
Am. J. Psychiatry 2007;164:1858-1865.
ABSTRACT
| FULL TEXT
|
